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ABSTRACT 
Aging has been an important hallmark of the world’s population for the last decades.  
Some of the frequent alterations observed in older individuals are the progressive decline in 
immune function (immunosenescence) and in cognitive performance.  In fact, in the last few 
years an increased body of evidences has highlighted the strong interaction between the immune 
system and cognitive functions. Particularly, the “low-grade inflammation”, frequently observed in 
older individuals, has been associated with cognitive decline. Moreover, immunocompromised 
individuals present cognitive dysfunction that is restored when the levels of immune cells return 
to normal. The findings follow animal data evidencing that mice devoid of adaptive immune 
system present cognitive deficits, which are reverted by T cell replenishment.  
In this project we are using a novel strategy to investigate possible correlations between 
“immunosenescence phenotype” and “cognitive phenotypes” in a well characterized cohort of 
healthy agers with distinct cognitive performances. To achieve this objective we assessed the 
most relevant adaptive immune cell populations (lymphocytes, CD4+ and CD8+ T cell 
compartments and regulatory T cells) by flow cytometry and compared them between good and 
poor cognitive performers. We observed that poor cognitive performance was associated with 
higher levels of effector memory CD4+ T cell and lower levels of naive CD8+ T cell. In order to 
understand if adaptive immune cell components could have distinct impacts on different 
cognitive function we correlated percentages and counts of adaptive immune cell populations 
with memory and general cognition and executive function scores. Since several statistical 
significant correlations were obtained, we performed, with those variables, multiple linear 
regression models to ascertain if the immune parameters would be good predictors of memory 
and general cognition and executive function taking into account age and gender. Statistical 
significant models revealed that, besides age and/or gender, effector memory CD4+ T cells were 
the immune parameter that showed to be a statistical significant predictor in all models. Since 
these cells are the major cytokine producers among T cells, the negative impact of the CD4+ 
effector memory T cells differential accumulation during aging can be mediated by the production 
of pro-inflammatory cytokines, which has been associated with cognitive impairments in older 
individuals.  
The results from this work prompted us to hypothesize that an immune system that aged 
faster (presents more effector memory CD4+ T cells), can be associated with poorer cognitive 
performance. The identification of this immune phenotype associated with a specific cognitive 
performance contributed to the increased knowledge about the key players associated with age-
related cognitive decline. 
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RESUMO 
Nas últimas décadas observou-se um envelhecimento crescente da população mundial. 
Algumas das alterações frequentemente observadas na população idosa são o declínio 
progressivo da função do sistema imunitário (imunosenescência) e do desempenho cognitivo. De 
facto, nos últimos anos tem havido um número crescente de estudos que destacam a interacção 
entre o sistema imunitário e a função cognitiva. Um dos exemplos é associação do ligeiro 
aumento do estado inflamatório, observado frequentemente na população mais envelhecida, 
com o declínio cognitivo. Para além disso, indivíduos imunossumprimidos apresentam défices 
cognitivos que desaparecem quando os números de células do sistema imunitário afectadas 
aumentam para valores normais. Estudos em animais também mostram que a depleção de 
linfócitos T está associada a défices cognitivos que podem ser revertidos pela administração de 
células T.  
Neste projecto estamos a usar uma estratégia inovadora para investigar possíveis 
correlações entre um “fenótipo de imunosenescência” e um “fenótipo cognitivo” numa 
população de idosos saudáveis com padrões distintos de perfis cognitivos. Para atingir este 
objectivo foram analisadas as populações de células mais relevantes do sistema imunitário 
adaptativo (linfócitos, compartimentos das células T CD4+ e CD8+ e células T reguladoras) por 
citometria de fluxo e comparadas entre indivíduos com má ou boa performance cognitiva. 
Observamos que os indivíduos com pior desempenho cognitivo apresentavam valores mais 
elevados de células T CD4+ efectoras de memória e valores mais baixos de células T CD8+ naive. 
Para esclarecer se a componente celular do sistema imunitário adaptativo poderia ter um 
impacto diferencial nos diferentes domínios cognitivos, fomos correlacionar percentagens e 
números totais de células do sistema imunitário adaptativo com os valores calculados para a 
função de memória e executiva. Uma vez obtidas várias correlações estatisticamente 
significativas, usamos essas variáveis num modelo de regressão múltipla de forma a averiguar se 
os parâmetros imunitários poderiam predizer as capacidades cognitivas como memória e função 
executiva, tendo em consideração os factores idade e género. Os modelos obtidos 
(estatisticamente significativos) revelaram que, para além da idade e/ou do género, as células T 
CD4+ efectoras de memória eram o parâmetro imunitário que apresentava ser consistentemente 
um bom preditor em todos os modelos. Uma vez que estas células são as principais produtoras 
de citocinas entre as células T, o impacto negativo da acumulação diferencial das células T CD4+ 
efectoras de memória durante o envelhecimento pode ser mediado pela produção de citocinas 
pró-inflamatórias, que têm sido associadas com o mau desemprenho cognitivo em indivíduos 
mais velhos.   
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Os resultados deste trabalho levaram-nos a colocar a hipótese de que um sistema 
imunitário que envelhece mais rápido (que apresenta mais células efectoras) pode estar 
associado a um pior desempenho cognitivo. A identificação de um fenótipo imunitário associado 
a um perfil cognitivo específico, contribui para o aumento do conhecimento acerca dos factores 
associados com o declínio cognitivo que normalmente ocorre durante o envelhecimento.  
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Population aging has been one of the last decade’s hallmarks and it is expected to 
increase in the years to come, being a major concern of modern societies. According to the 
United Nations Program on Aging, one out of every ten persons is now 60 years old or above, 
and by 2050 this number is expected to increase to one out of five (DESA United Nations 2001). 
The Portuguese population also reflects this trend. In the last 10 years the population with more 
than 65 years old increased from 16% to 19% and the aging index, which reflects the proportion 
of older population in relation to the younger population, increased from 102 in 2001 to 128 in 
2011, meaning that for each 100 young there are 128 older individuals (Instituto Nacional de 
Estatística 2012).  
Aging is a multidimensional process related with social, physical, biological/biochemical, 
(brain) structural, cognitive and psychological parameters. Thus, the current trend and estimation 
on population aging seems extremely worrying when considering that aging is associated with 
several pathologies or decline of several abilities. Among them, one of the functions that 
gradually decline with age is cognition (Salthouse 2010; Deary et al. 2009; Paulo et al. 2011). As 
such, accompanying the clinical measures that support living longer years, and to ensure the 
mental and cognitive wellbeing of older individuals into their elder years, the scientific community 
faces the need to identify predictive factors for cognitive aging so to understand, halt or delay 
cognitive-aging related aspects. This would ultimately allow for continued functionality and 
independence of the individual throughout aging, positively reflecting in his/her continued overall 
quality of life. 
1.1. AGE-RELATED COGNITIVE DECLINE  
During normal aging, the trajectory of cognitive performance is a heterogeneous process 
that affects differently the two major (so termed) types of cognitive processes: the “crystalized” 
and the “fluid” abilities. In general, the “crystalized” abilities, which are the acquired knowledge, 
can be evaluated by tests of general information or vocabulary; while the more “fluid” abilities, 
which including reasoning, memory and speed capacity, can be evaluated by neurocognitive tests 
directed towards those parameters (that is, overall reasoning and novel problem solving)  
(Salthouse 2012). Summarily, it is overall considered, albeit with great variability and/or 
dispersion, that while for measures representing products of processing carried out in the past 
(knowledge) may not decline (or even increase), until middle age onward. The “fluid” abilities, 
that represent efficiency and effectiveness of processing carried out at the time of assessment, 
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may start to decline well previous to entering the “senior years” (Salthouse 2010; Salthouse 
2012; Salthouse 2009). This possibly means that the ability of solving novel problems is more 
sensitive to age than knowledge acquired during life (Salthouse 2012).  Regardless, all of our 
cognitive abilities are intrinsically important for carrying out daily activities, living independently 
and overall continued enriching lifestyle (Salthouse 2012). As such, their loss (cognitive decline) 
may lead to a progressive decline in the quality of life and it is, in fact, one of the most feared 
aspects of growing old, including underlying admissions to institutional care (Deary et al. 2009). 
Interestingly, however, cognitive performance in healthy aging is associated with an inter-
individual (diversity) and intra-individual (dispersion) variability (Paulo et al. 2011). While some 
people present cognitive decline with aging, others remain stable or even improve throughout life 
(Salthouse 2010), and also the same individual may perform differently in different cognitive 
domains (Salthouse 2010; Paulo et al. 2011) in different periods throughout aging. To 
understand the mechanisms behind the variability there is an increased research effort trying to 
identify the predictors for this differential cognitive aging. The approach ranges from identification 
of risk factors (or mechanisms) for cognitive decline in a multitude of parameters, including: 
genetics, general health, biological processes such as inflammation, neurobiological changes, 
diet, lifestyle, education, social engagement and socio-demographic/economic characteristics  
(Deary et al. 2009; Paulo et al. 2011). 
In a recent study from our group, healthy individuals, between 50 and 91 years old from 
the Minho region of Portugal, were submitted to a battery of neurocognitive and psychological 
tests to assess short-term verbal memory, verbal working memory, response inhibition/cognitive 
flexibility, verbal fluency, multiple trial verbal learning and memory, high level information 
processing speed, global cognitive status, and mood [evaluated by the geriatric depression scale 
(GDS)] (Santos et al. 2012). Using principal component analysis, four significant dimensions of 
cognitive performance and mood status were identified: memory (MEM) and executive function 
(EXE) (encompassing multiple test variables), and global cognitive status (MMSE) and mood 
(GDS) (both single test based dimensions). Cluster analysis revealed four different categories of 
cognitive performers (Figure 1): a “good” (cognitive) group subdivided as C1 and C2, and a 
“poor(er)” (cognitive) group subdivided as C3 and C4 cognitive performers. Interestingly, 
however, mood was the principal factor contributing to the separation between C1 and C2, as 
well as, between C3 and C4 (Santos et al. 2012), indicating that it may work as a precipitating 
factor within performance groups, while other factors (age, gender and educational status) may 
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underlie being already either in the “good” or “poor” group. For instance, previous work by the 
group, had shown that social inclusion and higher educational level are beneficial factors for the 
cognitive performance in older population (Paulo et al. 2011). 
 
Figure 1. Cluster analysis. Mean performance zscores by clusters in the MEM, EXEC, MMSE and GDS 
dimensions (adapted from (Santos et al. 2012)) 
1.2. IMMUNOSENESCENCE   
Likewise cognitive function, the immune system also progressively declines over the 
years, which is known as “immunosenescence”.  
The main role of the immune system is to perform the surveillance of the organism and 
participate in the maintenance of body homeostasis. Cells that constitute the immune system 
have the ability to distinguish between the self and the non-self and are divided in two main types 
of cells that constitute the innate and adaptive components of the immune system. The innate 
immune system identifies the non-self in a non-specific manner, while the adaptive immune 
response recognizes specific antigens. During immune response these two components of the 
immune system communicate with each other. This interaction is essential to establish effective 
immune response but it suffers alterations during aging, resulting in an increased susceptibility to 
certain infections, increased predisposition to autoimmune disorders and reduced response to 
vaccination (Orsini et al. 2012). 
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INNATE IMMUNITY  
 The innate immune system is composed by several cell types including neutrophils, 
monocytes/macrophages, dendritic cells (DC), natural killer (NK) and natural killer T (NKT) cells, 
which constitute the first line of defense. It is usually triggered when non-self molecules are 
recognized by pattern recognition receptors, such us toll-like receptors (TLR) that recognize 
molecules conserved among a broad group of pathogens. As we age, the innate immunity 
undergo both quantitative and quantitative alterations (Shaw et al. 2010). 
 Neutrophils constitute the first immune cell defense against bacteria, yeast and fungal 
infections, being the first cells to arrive at the sites of damage. They fight against infection 
through the generation of reactive oxygen and nitrogen species, release of proteolytic enzymes, 
and microbicidal peptides from cytoplasmic granules (Shaw et al. 2010). While the number of 
neutrophils is well preserved in the older individuals, some of their functions are reduced, for 
instance reduced chemotactic activity, phagocytic capacity, free radicals production (Shaw et al. 
2010; Larbi et al. 2008; Wenisch et al. 2000; Hakim et al. 2004). These changes result in the 
reduced ability to control infections, but also inhibit the interaction with the adaptive immune 
system (Wessels et al. 2010). 
 Monocytes, which are important in recognition and clearance of invaders through their 
pattern recognition receptors, represent a highly mobile component of the innate immune system 
located mainly in the spleen and blood. They respond to inflammation differentiating into antigen 
presenting cells (APC) such as macrophages and dendritic cells (Shaw et al. 2010). These cells 
process antigens and present them to T cells in the context of MHC (major histocompatibility 
complex). T cell recognizes these complexes through their T-cell receptors (TCRs). With age, 
although there is an increase of monocytes in absolute numbers, their function has been 
described to become impaired (Della Bella et al. 2007). The increase in monocyte numbers also 
contrasts with a decreased in macrophages function such as reduced activation through TLR  
(Shaw et al. 2010), chemotaxis and phagocytic activity (Panda et al. 2009), decreased antigen 
presentation possibly due the reduction of MHC class II expression with age (Larbi et al. 2008; 
Villanueva et al. 1990) and also increased pro-inflammatory cytokine production (Fulop et al. 
2011).  
 DC are professional APC and play critical roles in the initiation and definition of the 
immune response profile linking the innate and adaptive immunity (MacDonald et al. 2002). They 
capture and process antigens in the periphery and migrate to the draining lymph nodes where 
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they present the antigens to T cells, inducing an antigen specific response by the adaptive 
immune system (Orsini et al. 2012). In general, aging induces a decrease in DC function. 
Reports suggest that DC present impairments in phagocytic and migration functions, alterations 
in the antigen presentation capacity and cytokine output (Shaw et al. 2010; Fulop et al. 2011; 
Della Bella et al. 2007). Regarding the age-related numerical alterations, various studies, up to 
now, have shown controversial results: while some report no alterations either in terms of 
phenotype or number, others demonstrate that aging is associated with decreased in total 
number of blood DC and in the two main subsets (lymphoid and myeloid subsets) (Orsini et al. 
2012; Fulop et al. 2011; Jing et al. 2009). 
 NK and NKT cells are cytotoxic cells that play a significant role in innate defense against 
viral infected cells and tumors. Besides their cytotoxic activity, NK(T) cells express cytokines and 
chemokines that are required at driving the adaptive immune response (Solana & Mariani 2000; 
Mocchegiani et al. 2009). In humans, NK can be subdivided taking into account the expression 
of CD56 (CD56bright cells and CD56dimNK cells) (Chidrawar et al. 2006). Older individuals present 
increased levels of CD56dimNK cells and, despite the total stability of NK cytotoxicity, the “per-cell” 
basis cytotoxicity is impaired (Solana & Mariani 2000; Mocchegiani et al. 2009; Borrego et al. 
1999). On the other hand, the number of CD56brightNK cells within the peripheral blood declines 
with aging, impairing the communication with the adaptive immune system (Chidrawar et al. 
2006). Aging is also associated with the reduction of cytokines and chemokines production 
(CCL5, MIP1α, IL-8, INF-γ) upon NK cell activation (Mocchegiani et al. 2009).  
ADAPTIVE IMMUNITY  
One of the main functions of the innate immune system is the activation of the adaptive 
immunity, which is composed by highly specialized cells and processes that, for example, 
eliminate or prevent pathogen growth in a pathogen-antigen-specific manner. This protection is 
mediated by B- and T-lymphocytes following the exposure to specific antigen and is also 
characterized by immunologic memory. The senescence of adaptive immune system is reflected 
in the alteration of cell compartments, mainly on T cell subsets (Fulop et al. 2011).  
T cells are responsible for cell-mediated immunity through the recognition of a specific 
antigen by the TCR in the context of MHC molecules. Their precursors are produced in the bone 
marrow but only fully differentiate in the thymus, where they acquire distinct phenotypes: 
expression of the co-receptor CD4, becoming helper T-lymphocytes (Th cells), or expression of 
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the CD8 co-receptor to be cytotoxic T-lymphocytes (Tc cells). The T cell population can be divided 
in several subsets based on their phenotype, which is characterized by the expression of cell 
surface receptors, such as, CD45RA and CD45RO (receptors involved in T cell activation), CCR7 
(lymph node homing receptor), CD27 and CD28 (co-stimulation receptors) (Okada et al. 2008; 
Appay et al. 2008). The cells that compose the T cell compartments are: 1) naive T cells 
(CD45RA+CD45RO-CCR7+), that have not yet contacted with their cognate antigen; 2) central 
memory (CM) T cells (CD45RA-CD45RO+CCR7+), previously activated but with the capacity to be 
maintained in the absence of antigenic stimulation and have the ability to expand rapidly upon 
secondary challenge; 3) effector memory (EM) T cells (CD45RA-CD45RO+CCR7-) are the ones 
found in sites of active antigenic stimulation;  and 4) late differentiated (LD) T cells, characterized 
by the re-expression of CD45RA lacking the expression of CCR7, are considered end-stage 
differentiated effectors with a major representation in CD8+ T cell subset (Appay et al. 2008; 
Okada et al. 2008; Saule et al. 2006). The expression of CD28, a co-stimulatory signal, is also 
used to distinguish different subsets within the ones that were referred above. Moreover, the loss 
of CD28 expression is also considered one of the most consistent immunological markers of 
aging (Saule et al. 2006; Gupta et al. 2004).  
Although peripheral T cell numbers do not diminish with age, one of the most described 
changes during immunosenescence is the proportion of T cells compartments and the CD4/CD8 
ratio alterations (Hakim et al. 2004; Macaulay et al. 2013). Older individuals present a reduction 
of naive T cells (most probably associated with reduced thymus output) and an accumulation of 
memory T cells, which also impacts on cytokine production (Hakim et al. 2004). The memory T 
cells increase in the CD4+ subsets is mainly caused by a raise on the CM and EM cells and in the 
CD8+ subsets by EM and LD cells (Saule et al. 2006). Reduced thymic activity and the expansion 
of peripheral T cell leads to a reduced diversity of the TCR repertoire (Hakim et al. 2004; Goronzy 
& Weyand 2005).  
An increased number and proportion of regulatory CD4+T cells (Tregs) has been also 
shown as an characteristic of aging (Orsini et al. 2012; Gregg et al. 2005; Lefebvre & Haynes 
2012).  However, these results are not so clear since other studies showed no differences in the 
frequency of this cell population between young and older individuals (Hwang et al. 2009; 
Santner-Nanan et al. 2008). Tregs function as immunomodulators through the production of 
cytokines such as IL-10 and TGF-β, and maintain immune cell tolerance by inhibiting several 
cells such as T cells, NK cells and DC. The increased frequency of these cells has been 
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suggested to contribute to the impaired immunity observed at advanced age, possibly because 
there is also loss or impairment of their main functions (Fulop et al. 2011; Lefebvre & Haynes 
2012; Hwang et al. 2009).  
B cells are generated in the bone marrow and produce antibodies (also known as 
immunoglobulins) upon stimulation in a T cell-dependent or independent manner, making them 
vital for the humoral immunity. The main functions of B cells are the production of 
immunoglobulins against specific antigens, function as APCs and develop into memory cells after 
activation. B cells were also described as having important regulatory functions (Ongrádi & 
Kövesdi 2011). During aging, the overall number of B cells seems to be stable or decrease 
moderately (Ongrádi & Kövesdi 2011; Colonna-Romano et al. 2003), and the main alterations 
observed are in the cell compartments. An accumulation of memory B cells, a decreased in T-
independent antibodies production by B cells (while T-dependent antibodies production do not 
change significantly) and loss of naive B cells has been suggested as hallmarks of 
immunosenescence (Colonna-Romano et al. 2003; Colonna-Romano et al. 2008). B cell 
functional alterations are also observed in aged individuals, such as antibody diversity and 
production (Frasca et al. 2005). The antibodies produced by lifelong B cells are commonly of low 
affinity (Larbi et al. 2008; Ongrádi & Kövesdi 2011) and it is also observed an increased 
production of immunoglobulin from specific classes, like IgG and IgA, and reduction or no 
alterations on proportion of others, such as IgM and IgD (Ongrádi & Kövesdi 2011; Paganelli et 
al. 1992). 
All the alterations of the immune system have an impact on immune response mediators 
that are produced by these cells, such as cytokines and chemokines. In fact, due to the 
functional alterations of the immune system that commonly occurs with aging, older individuals 
present 2-4 fold increases in plasma/serum levels of pro-inflammatory mediators, such as 
cytokines and acute phase proteins, but far from the increases observed during acute infections  
(Krabbe et al. 2004). This chronic-low grade inflammation observed in elderly is also called as 
“inflammaging”. Most studies focused on IL-6 and showed increased levels of this cytokine, as 
well as tumor necrosis factor (TNF), with advancing age (Krabbe et al. 2004). Aging is also 
associated with increased levels of C-reactive protein (CRP) (Capuron et al. 2011). 
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1.3. THE ROLE OF THE IMMUNE SYSTEM ON COGNITIVE FUNCTIONS  
In the last decade, some researchers raised the notion that the immune system plays a 
general supportive role in brain function, including cognitive abilities and neurogenesis (Kipnis et 
al. 2008; Schwartz & Shechter 2010). These studies support the idea that, throughout life, the 
brain is not “immune privileged” but rather “enjoys the privilege” of immune-dependent 
maintenance. Experimental evidences that support this theory, concerning cognitive functions, 
have been provided by animal models that lack peripheral immune cells. For instance, severe 
combined immune deficiency (SCID) mice, which are devoid of B and T cells, and nude mice, 
which are devoid of mature T cells, present a significant impairment in the hippocampal-
dependent spatial learning and memory in several cognitive tasks (Kipnis et al. 2004; Ron-Harel 
et al. 2008; Brynskikh et al. 2008). These cognitive deficits can be reverted by replenishing the 
mouse with T cells (Kipnis et al. 2004; Ron-Harel et al. 2008; Brynskikh et al. 2008), but not 
with other immune cells (Brynskikh et al. 2008), meaning that T cells constitute the main 
immune cell population affecting cognitive behavior (Figure 2). Moreover, other studies 
demonstrated that not only a lifelong immune deficiency, which can affect brain development in 
young mice, but also the imposition of immune deficiency in adulthood is sufficient to cause 
cognitive deficits. These studies proved that irradiated wild-type mice after transplantation with 
SCID-bone marrow present spatial learning and memory loss (Brynskikh et al. 2008; Ron-Harel et 
al. 2008) (Figure 2), and also acute suppression of T cells using immunosuppressive drugs, 
currently used in clinical trials or in disease treatment, would yield similar phenotype of cognitive 
impairment (Derecki et al. 2010). Furthermore, CD4-depleted mice present a significantly 
impaired performance during the reversal learning of morris water maze (MWM) (Wolf et al. 
2009), which leads to consider that the key players between adaptive immunity and cognitive 
functions are CD4+ T cells.  
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Figure 2. Immune system availability and cognitive function. Depletion of adaptive immunity from wild-type 
mice by a split-dose irradiation, followed by injection of bone marrow from SCID mice impairs cognitive function, 
whereas replacement of bone marrow with that of autologous (wild type) WT mice does not. The cognitive decline 
observed as a result of acute depletion of the immune system and the cognitive decline associated with long-lasting 
immunodeficiency are both reversible by injection of T cells from wild-type donors (Kipnis et al. 2008). 
 
Some authors argue that a better cognitive performance is associated with the presence 
of T cells that recognize central nervous system (CNS)-specific antigens. Transgenic mice 
possessing mainly T cells receptors specific to myelin based protein, a CNS antigen, perform 
better in MWM than their wild type controls while. In addition, transgenic mice for ovalbumin (an 
irrelevant non-specific antigen) specific T cell receptors, perform worse (Ziv et al. 2006). 
Moreover, cognitive impairment induced by neurotransmitter dysfunctions in animal models can 
also be reverted boosting T cell activation by vaccination, using copolymer-1, which is a random 
polymer of four amino acids enriched in myelin based protein (Kipnis et al. 2004). These findings 
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support the notion of a “protective autoimmunity” – T cells that recognize self and CNS-specific 
antigens are needed to maintain the proper brain function, such as cognition (Schwartz & 
Shechter 2010) – and that T cells present a pro-cognitive properties (Kipnis et al. 2012). 
Alterations in homeostasis, such as learning associated stress and brain activity, may release 
mediators (brain-derived molecular cues) into cerebrospinal fluid (CSF) or blood that function as 
a trigger for immune cells to assume a pro-cognitive phenotype (Kipnis et al. 2012). 
In accordance with the data in animal models, individuals with a marked decrease in T 
cells also present deficits in cognitive functions. For instance, humans that are 
immunocompromised (acquired immunodeficiency syndrome patients and patients submitted to 
immunosuppressive chemotherapy treatment) present cognitive dysfunction, and when the levels 
of immune cells return to normal there is an improvement of the cognitive function (Kipnis et al. 
2008; Cysique et al. 2009; Hess & Insel 2007). However, care should be taken in the 
interpretation of these results due to the potential confounding factors inherent to the health state 
of the individuals. 
As previously shown, T cells apparently have an important role in the maintenance of 
cognitive functions, however, some aspects are far from being understood. The location and what 
are the mechanisms underlying T cell effect on cognitive function are two main issues that have 
been addressed in the last years but need to be further explored. 
LOCALIZATION OF T CELLS THAT AFFECT COGNITIVE FUNCTIONS 
It is known that no T cells are detectable, in healthy physiological conditions, in the 
parenchyma of naive or cognitive trained mice, but in areas immediately adjacent to the 
parenchyma (such as choroid plexus and subarachnoid meningeal spaces), which are highly 
enriched with blood vessels (Derecki et al. 2010). Additionally, it was recently reviewed that 
“protective autoimmunity” occurs through intracranial immune surveillance, and that brain 
homeostasis is maintained by a supportive immune response within the brain’s barriers (Ron-
Harel et al. 2011; Schwartz & Shechter 2010). Supporting these concepts, it has been proved 
that peripheral immune modulation or the performance of cognitive tasks induces substantial 
immunological changes in the brain barriers, mainly on meninges. The elimination of T cells from 
the meningeal spaces through the inhibition of T cells migration into the CNS seems to induce 
cognitive deficits, similar to the ones observed after peripheral T cell depletion (Derecki et al. 
2010), meaning that meninges need to be populated by T cells to ensure proper cognitive 
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abilities. However, it was not proved that the treatment with antibodies anti-very late antigen-4 
(VLA-4), which was used to inhibit T cells migration into the CNS, did not induce also peripheral 
lymphopenia. Besides changing immune cell populations, adaptive immune modulation also 
affects the phenotype of meningeal cells. Depletion of T cells from the meningeal spaces skew 
meningeal myeloid cells toward pro-inflammatory phenotype (IL-12 and/or TNF)  (Derecki et al. 
2010), and the same phenotype was evident in SCID mice as well as IL-4 -/- animals. Moreover, 
after performance of a cognitive task (MWM-training) meninges presented increased numbers of 
activated CD4+ T cells (and not CD8) with an IL-4-production phenotype, whereas interferon (IFN)-
γ-producing T cells did not change substantially after cognitive training, conferring to IL-4-
producing T cells a role in the balance/maintenance of meningeal homeostasis  (Derecki et al. 
2010).  
Besides T cells, myeloid cells seem also to play a role in cognition but it is not known if 
the effect is (in)dependent of T cells. A recent study demonstrated that the induction of an 
“alternatively” activated M2 phenotype (an anti-inflammatory phenotype characterized by the 
production of IL-10 and by the expression of CD206) of myeloid cells, achieved by skewing them 
in vitro with IL-4, and their subsequent intravenously injection into mice devoid of T cells, results 
in the reverse of pro-inflammatory skew meningeal phenotype and improved learning and 
memory (Derecki et al. 2011). These results suggest that M2 cells could contribute to a T cell-
independent manner to improve cognitive functions associated with T cells malfunctions, being a 
possible therapeutic target.   
MECHANISMS UNDERLYING THE EFFECT OF IMMUNE CELLS ON COGNITIVE FUNCTIONS 
Hippocampal neurogenesis, which is maintained throughout adult life, has been defined 
as a prerequisite for certain aspects of brain cognitive activity (Leuner et al. 2006). Moreover, 
immune cells, besides being associated with cognitive functions (spatial learning abilities), also 
contribute to the maintenance of neurogenesis (Ziv & Schwartz 2008; Ziv et al. 2006). 
Hippocampal neurogenesis in immune-deficient mice is markedly impaired and cannot be 
enhanced by environment enrichment, which normally increases hippocampal neurogenesis (Ziv 
et al. 2006). Ziv and colleagues, showed that neurogenesis is dependent on T cells, namely T 
cells that recognize CNS antigens (in this case cells that recognize myelin based protein) (Ziv et 
al. 2006). Furthermore, CD4+ T cells, besides being key players on cognitive behavior, also affect 
hippocampal neurogenesis. Systemic depletion of CD4+ T lymphocytes, but not CD8+ T 
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lymphocytes or B cells, lead to a reduction in hippocampal neurogenesis, and the repopulation 
with CD4+ T cells, but not with CD8+ T cells, increase hippocampal neurogenesis in mice devoid of 
lymphocytes (Wolf et al. 2009). These results prompted us to consider that CD4+ T cells provide 
a neuroimmunological link in the control of adult hippocampal neurogenesis and consequently on 
cognitive function.  
 Other possible mechanism by which the immune system maintains brain plasticity, 
such as cognitive activity, is through regulation of brain-derived neurotrophic factor (BDNF) 
expression (Yirmiya & Goshen 2011). BDNF is an important molecule for hippocampal-dependent 
learning and memory and also adult hippocampal neurogenesis (Heldt et al. 2007; Donovan et 
al. 2008; Ron-Harel & Schwartz 2009). T cells that recognize CNS-specific antigens and CD4+ T 
cells are able to increase BDNF expression in the brain parenchyma (Wolf et al. 2009; Ziv et al. 
2006). Astrocytes cultures treated with IL-4, an immunomodulatory cytokine, also present 
increased levels of BDNF expression, whereas the culture with pro-inflammatory cytokines leads 
to a reduced expression (Derecki et al. 2010). Possibly T cell could affect levels of parenchymal 
BDNF expression through the regulation of meningeal cytokines.  
 Also considering aspects along the same line as the ones here discussed, Schwartz 
and Shechter (2010) proposed a model that aims to explain the link between “protective 
autoimmunity” and “CNS immunesurveilance”, and how it can affect, for instance, cognitive 
functions (Figure 3). In the model, memory CD4+T cells that recognize their cognate antigen 
presented at the barriers of the CNS, namely the choroid plexus, are allowed to enter in the CSF 
but not in the brain parenchyma. Their model further suggests that these lymphocytes are 
probably skewed toward an immunomodulatory phenotype, characterized by the production of IL-
4 and growth/survival factors. Even though leukocytes cannot reach brain parenchyma, their 
derived molecules produced in the barriers or in the CSF can affect parenchyma cellular and 
molecular mechanisms, such as modulation of local expression of BDNF and neurogenesis 
(Schwartz & Shechter 2010). These alterations may be reflected by altered cognitive functions.   
 
 
 
 
 
 
 15 
 
 
 
Figure 3. CNS immunosurveillance by self-specific T lymphocytes is neuroprotective. Memory T cells enter 
the cerebrospinal fluid (CSF) by transmigration from blood vessels into the stroma of the choroid plexus (CP) (1). CD4+ 
memory T cells are primed in the CP by antigen-presenting cells (APCs) presenting CNS-self-antigen (Ag) (2). On 
recognition of self-Ag, T lymphocytes cross the epithelial blood-CSF-barriers (BCSFB) into the CSF (3). Activated self-
recognizing T lymphocytes patrol the SAS, in which the CSF circulates, in a process termed as immunosurveillance (4). 
Under physiological conditions, no infiltration to the CNS parenchyma occurs. IL-4 reaches the parenchyma through the 
CSF circulation, and induces secretion of neuroprotective substances (i.e. BDNF and IGF-1) by local microglia (5). 
Exposure to acute psychological stress induces a pro-inflammatory phenotype in resident microglia, characterized by 
secretion of reactive oxygen species (ROS), nitric oxide (NO), and increased levels of proinflammatory cytokines (i.e. IL-
1β, TNF-α and IL-6) (6). Their model suggests that ROS exit the parenchyma to the CSF and serve as the ‘‘third signal’’ 
which facilitate T cell activation despite low antigen presentation (7). This stimulation occurs either by acting directly on T 
cells or by priming the APCs. T cells activated in response to increased toxicity are expected to secrete increased levels 
of IL-4, which then penetrates the parenchyma, and binds to IL4R on the cytotoxic microglia (8). Exposure of cytotoxic 
microglia to IL-4 causes downregulation of proinflammatory factor secretion, and induces expression of neuroprotective 
factors (BDNF, IGF-1), which support restoration of homeostasis (9) (adapted from (Schwartz & Shechter 2010; Ron-
Harel et al. 2011) 
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RELATION BETWEEN AGE-RELATED COGNITIVE DEFICITS AND IMMUNITY 
Functional features of brain aging are caused by cells becoming less able to respond to 
stress, neurons impaired ability to adapt to and rebound from potentially damaging alterations 
from the local environment and the endocrine milieu (Stranahan & Mattson 2012): that is, in 
others words,  a deviation from the homeostasis. On this, recently, age related brain impairment 
has been attributed, at least in part, to the immune system aging (Ron-Harel & Schwartz 2009). 
Possibly, due to all the age-related peripheral immune alterations, aging results in a defective 
CNS immunesurveillance leading to a reduced ability to cope and restore brain homeostasis 
(Schwartz & Shechter 2010). Ron-Harel and colleagues suggested that age-related spatial 
memory loss could be reverted by boosting T-cell activation through homeostatic-driven 
proliferation. Once more, they aimed to demonstrate that age-attenuated immune response could 
be correlated with spatial and memory loss in old mice (Ron-Harel et al. 2008). 
As mentioned, several studies suggest that neurogenesis is dependent on T cells, and 
along with the fact that in elderly there is a decrease in hippocampal neurogenesis (Galvan & Jin 
2007), it was proposed that the reduced neurogenesis associated with aging might be an 
outcome of, among others factors, reduced immune based maintenance or an overpowering 
local inflammation in elderly (Ron-Harel & Schwartz 2009). Actually, the low-grade inflammation 
observed in elderly has been associated with their cognitive decline (Hakim et al. 2004; Fulop et 
al. 2011; Trollor et al. 2010; Dimopoulos et al. 2006). Furthermore, blood-borne factors 
characteristics of and old systemic environment are able to impair spatial learning and memory 
and also neurogenesis in young mice (Villeda et al. 2011). Villeda and colleagues demonstrated 
that using heterochronic parabiosis (old and young mice sharing circulatory system), blood-borne 
factors present in the systemic milieu promote adult neurogenesis in old mice and inhibit in 
young (Villeda et al. 2011). It was also shown that the exposition of a young mouse to plasma 
from an old mice decreased synaptic plasticity and spatial learning and memory. The impairment 
in cognition seemed to be caused by increased levels of CCL11 and, in fact, young mice injected 
with CCL11 present decreased adult neurogenesis and impaired learning and memory (Villeda et 
al. 2011). Interestingly, plasma and CSF levels of CCL11 in older individuals are also increased 
when compared with young individuals (Villeda et al. 2011).  
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Altogether these facts indicate that the decline in cognitive functions observed during 
aging can be in part attributed to changes on peripheral immune system, such as alterations on 
immune cells or circulatory signaling immune molecules.  
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2. RESEARCH OBJECTIVES  
  
 20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 21 
 
The central hypothesis of this work is that distinct immunosenescence profiles might 
directly (cor)relate with differential cognitive abilities in older individuals. This project is relevant 
since it leads to the identification of an “immunological phenotype” correlated with patterns of 
cognitive aging, contributing to the increased knowledge concerning the factors associated with 
age-related cognitive decline.  
 
Specifically, in a cohort of aged individuals with distinct cognitive performances we aimed 
to: 
1. Analyze the immune cell populations from the adaptive immune system, focusing on 
T cells compartments and regulatory T cells, by flow cytometry. 
2. Correlate the immune cell phenotype with the distinct cognitive performances and 
domains that were already evaluated in the same cohort.  
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3. MATERIAL AND METHODS  
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3.1. PARTICIPANTS CHARACTERIZATION 
The 119 participants enrolled in this project were recruited from a cohort (n=1051 
individuals), clinically and cognitively characterized, originated in the context of the SWITCHBOX 
project (Santos et al., 2012). The participants from the initial cohort are older community-
dwelling individuals living in the Minho Region of Portugal and are representative of the country’s 
population in terms of age, gender and formal education level. Participants with incapacity 
and/or inability to attend the clinical and neuropsychological sessions, who were diagnosed with 
dementia and/or inability to understand informed concept, with disorders of the central nervous 
system as well as overt thyroid pathology and infectious diseases were excluded. 
The cohort was established in accordance with the principles expressed in the 
Declaration of Helsinki and the work approved by the national ethical committee (Comissão 
Nacional de Protecção de Dados) and by local ethics review boards. All the participants gave 
voluntary informed signed consent. 
A team of trained psychologists assessed the cognitive and mood profile of the 
participants. Briefly, cognitive profile were established using a battery of neurocognitive and 
psychological tests selected to evaluate short-term verbal memory, verbal working memory, 
response inhibition/cognitive flexibility, verbal fluency, multiple trial verbal learning and memory, 
high level information processing speed, global cognitive status and mood. Using a principle 
component analysis the neurocognitive/psychological test variables were grouped in 3 
dimensions: memory (MEM; composite dimension), general cognition and executive function 
(EXEC; composite dimension) and mood (GDS; single parameter). The values of each dimension 
were calculated based on the weight of each test and were transformed in zscores. All the 
statistical analysis of the cognitive evaluation followed the reported by Santos et al. (2012). From 
cluster analysis, individuals were divided into 4 groups (C1 to C4) taking into account their 
cognitive performance and mood state: C1 group members presenting the better cognitive 
performance whereas C4 the worst (C1>C2>C3>C4), and C1 and C3 presenting the better mood 
state whereas C2 and C4 a lowered (more depressed) mood state.  
For this study participants from both “good” (C1+C2) and “poor” (C3+C4) cognitive 
groups were recruited. The study enrolled 119 participants (56 or 47% were women), 64 from 
the good cognitive performance groups and 55 from the poor cognitive performance groups. 
Descriptive information in terms of age and gender of the total participants and of the good and 
poor cognitive performance groups is indicated on Table 1. 
 26 
 
Total Good Poor
Age
    Mean 65.86 64.27 67.71
    SD 8.40 8.30 8.21
    [51-60] 39 26 13
    [61-70] 45 22 23
    [71-80] 31 15 16
    [81-87] 4 1 3
Gender 
    Males 63 37 26
    Females 56 27 29
Total 119 64 55
SD= Standard Deviation
Table 1. Sample characterization in terms of age and gender. 
 
3.2. FLOW CYTOMETRY ANALYSIS 
Blood was collected to EDTA-blood collection tubes and processed for multiparametric 
flow cytometry analysis on the day of collection. Blood samples collected in the same day were 
also sent for Hospital de Braga’s Laboratories to perform a leukogram. 
T CELL COMPARTMENTS CHARACTERIZATION  
One-hundred μL of whole blood was incubated for 15 min, at room temperature, with the 
following combination of monoclonal antibodies:  V500-conjugated α-CD3 (clone UCHT1; from 
BD Biosciences, San Jose, CA, USA), APC-Cy7-conjugated  α-CD4 (clone  RPA-T4), Pacific Blue-
conjugated  α-CD8 (clone  RPA-T8), FITC-conjugated  α-CD45RA (clone  HI100), PerCP-Cy5.5-
conjugated α-CD45RO (clone UCHL1), Alexa Fluor 647-conjugated α-CD197/CCR7 (clone 
TG8/CCR7, all purchased from Biolegend,  San Diego, CA, USA).  Afterwards, erythrocytes were 
lysed upon incubation for 15 min, at room temperature, in FACS Lysis Buffer (BD Biosciences, 
San Jose, CA, USA) and washed on FACS buffer (3% BSA in PBS, 0.01 % Azida).  
Lymphocytes were defined by low side scatter and low forward scatter, and within this 
population, the compartments of CD4+ T cells (CD3+CD4+) and CD8+ T cells (CD3+CD8+) were 
defined as naïve (CD45RA+CD45RO-CCR7+), CM (CD45RA-CD45RO+CCR7+), EM (CD45RA-
CD45RO+CCR7-) and LD (CD45RA+CD45RO-CCR7-). Analysis´s strategy is presented in Annexes 
(Figure 1).  
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TREGS CHARACTERIZATION 
Peripheral blood mononuclear cells (PBMCs) were obtained by gradient centrifugation 
using Histopaque 1077 (Sigma-Aldrich, St. Louis, MO, USA) for 30 min, at room temperature, 
according to the manufacturer's instructions. Cells were collected, washed twice with sterile PBS 
and counted using trypan blue exclusion dye. One million and a half of fresh PBMCs were cell 
surface stained upon incubation  for 15 min, at room temperature,  with V500-conjugated  α-CD3 
(clone UCHT1; from BD Biosciences, San Jose, CA, USA), APC-Cy7-conjugated α-CD4 (clone  
RPA-T4), FITC-conjugated  α-CD45RA (clone  HI100), PE-Cy7-conjugated  α-CD127 (clone 
A019D5), Brilliant Violet 421-conjugated α-CD25 (clone BC96; all purchased from Biolegend, 
San Diego, CA, USA). Afterwards, PBMCs were washed with FACS buffer, fixed and permeabilized 
using Foxp3 permeabilization buffer for 30 min at 4°C (from eBioscience, San Diego, CA, USA) 
and stained with PE-conjugated α-FOXP3 (clone  PCH101,  eBioscience, San Diego, CA, USA) for 
30 min at 4°C. At the end, samples were washed twice with eFluor NC flow cytometry staining 
buffer (from eBioscience, San Diego, CA, USA).  
Regulatory T cells were defined within lymphocytes (low side and forward scatter) as 
CD3+CD4+CD127lowCD25+Foxp3+. The analysis strategy is presented in the Annexes (Figure 2). 
FLOW CYTOMETRY DATA ANALYSIS 
All samples were acquired on a BD LSR II flow cytometer using FACS DIVA software and 
data were analyzed using FlowJo Software (Tree Star, OR, USA).   
3.3. STATISTICAL ANALYSIS 
This study aimed to identify any adaptive immune system profile correlated with distinct 
cognitive performances in a senior population. To achieve the objective the following analysis 
were performed. Cell counts were accessed multiplying the percentage of each population among 
total cells by the leukocyte counts performed in the Hospital de Braga’s Laboratories. MEM, 
EXEC and GDS are present in zscores that were previously calculated based on the initial cohort 
by (Santos et al. 2012; unpublished data). To evaluate normal distribution of the variables, 
skewness and kurtosis values were calculated and approximate normal distribution was defined 
for variables with absolute values of skewness below 3 and kurtosis below 8 (Kline 2005). 
Levene's Test was used to evaluate equality of variances.  
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To compare adaptive immune cell populations (cell counts and percentages) between 
good and poor cognitive performance groups (descriptive statistics of variables are presented in 
Annexes Table 1-3) an independent-sample t-Test was performed for variables with normal 
distribution and a Mann-Whitney U Test for variables with non-normal distribution. Significance 
was considered for p-values below 0.05 and to quantify the strength of the differences Cohen´s d 
was calculated as a measure of effect size (0.2 is considered a small effect size, 0.5 a medium 
effect size and 0.8 a large effect size)(Kotrlik & Williams 2003). 
To correlate adaptive immune cell populations (cell counts and percentages) with 
cognitive (MEM and EXEC) dimensions and mood (GDS) state a Pearson´s Correlation 
Coefficients Test was performed for variables with normal distribution and a Spearman´s Rank 
Correlation Coefficient Test for variables with non-normal distribution. The coefficient of 
determination (R2) was calculated as a measure of effect size (0.0196 is considered a small 
effect size, 0.1300 is a medium effect size and 0.2600 a large effect size)(Kotrlik & Williams 
2003). 
Multiple linear logistic regression analysis was performed to identify if relevant adaptive 
immune cell populations (cell counts or percentages) could predict MEM, EXEC or GDS 
dimensions (dependent variables), controlling for gender and age (considering these two 
variables as independent variables together with immune cell populations). The variables 
included in the models as predictors were the ones that presented statistical significant 
correlations with MEM, EXEC or GDS. Variables with non-normal distribution and with Tolerance 
values below 0.4 (to avoid multicollinearity between variables) were excluded from the model. 
The statistical procedures were performed in IBM SPSS Version 20 (IBM Corp, Armonk, NY, 
USA) and graph’s representation using GraphPad Prism version 6 (GraphPad Software, La Jolla 
California, USA).  
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4.1 . CHARACTERIZATION OF LEUKOCYTE PROFILE  
To characterize the white blood cells profile of the study participants, blood samples were 
collected, in the same day as the ones used to perform cytometry analysis, to assess counts of 
leukocytes (neutrophils, eosinophils, basophils, lymphocytes and monocytes). The vast majority 
of the participants present cell counts within normal range (Figure 4). No one was excluded from 
the analysis, even if presenting values outside the normal range in one of the cell populations.  
Comparing good and poor cognitive performers, no statistical significant differences are 
found in the number of the general immune cell populations (leukocytes, t(112)=-0.207, p=0.836; 
neutrophils, t(112)=-0.718, p=0.474; eosinophils, U(112)=1592, Z=-0.159, p=0.876; basophils, 
U(112)=1458, Z=-0.920, p=0.358; lymphocytes, t(112)=0.949, p=0.345; monocytes, t(112)=-0.461, 
p=0.646).  
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Distinct cognitive performers do not present differences in most general immune cell 
population counts. The large majority of the participants present leukocytes (A), neutrophils (B), eosinophils (C), 
basophils (D), lymphocyte (E) and monocyte (F) counts within normal values (represented by horizontal dashed 
lines). No differences are observed between good (white) and poor (black) cognitive performers. Each dot represents 
one individual and the line the mean of the group.  
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4.2.  ADAPTIVE IMMUNE CELL PROFILE: DIFFERENCES BETWEEN DISTINCT 
COGNITIVE PERFORMERS  
Even though the distinct cognitive performers do not present differences in the lymphocyte 
counts, some cell types of the adaptive immune system have been shown to play a crucial role in 
cognitive function (Brynskikh et al. 2008; Derecki et al. 2010; Kipnis et al. 2004; Kipnis et al. 
2012; Wolf et al. 2009; Ziv et al. 2006; Ziv & Schwartz 2008). Several studies, mainly in animal 
models, showed that a disruption of the homeostasis of the immune system impacts on the 
cognitive performance and the absence of T cells (namely CD4+) has been associated with 
cognitive impairment (Wolf et al. 2009; Ron-Harel et al. 2008; Kipnis et al. 2004; Brynskikh et al. 
2008).  
To identify whether lymphocytes and T cell profiles were associated with cognitive 
performance, cell counts and percentages were compared between good and poor cognitive 
performers (Figure 5).  
 
Figure 5. Distinct cognitive performers do not present differences in lymphocytes and T cell counts 
and percentages. No differences are observed between good (white) and poor (black) cognitive performers in 
lymphocytes, T cells, CD4+ T cells and CD8+ T cells counts (A), as well as in the percentages of these populations 
among total cells (B). Each dot represents one individual and the line the mean of the group.   
A 
B 
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No statistical significant differences are observed between good and poor cognitive 
performers in lymphocytes and T cells counts (lymphocytes, t(110)=0.885, p=0.378; T cells, 
U(110)=1430, Z=-0.778, p=0.437) or percentages of cells among total cells (will be here onward 
referred as percentage of cells) (lymphocytes, t(101.1)=-0.088, p=0.930; T cells, U(115)=1684.5, Z=-
0.090, p=0.928) and also in CD4+ and CD8+ T cells (counts: CD4+ T cells, t(110)=0.617, p=0.539; 
CD8+ T cells, t(110)=-0.196, p=0.845; percentage of cells: CD4+ T cells, t(95.6)=-0.842, p=0.402; CD8+ 
T cells, t(115)=-0.533, p=0.595). 
One of the major alterations of the adaptive immune system that occurs with aging is the 
alteration of T cell compartments (Saule et al. 2006). Aiming to understand if any association 
with cognitive performance was presented, the different cell compartments among CD4+ (Figure 
6) and CD8+ T cells (Figure 7) were analyzed between good and poor cognitive performers. 
Among the CD4+ T cells (Figure 6), the most represented compartment is the CM 
(M=38.84, SD=13.51), followed by naive (M=29.96, SD=13.03) and EM (M=20.12, SD=13.31); 
the least represented and almost inexistent is LD (M=2.38, SD=3.82). In comparison to the good 
performers, the poor cognitive performers present statistically significant higher levels of EM 
CD4+ T cells. The differences are observed either in cell counts (t(110)=-2.51, p=0.014, d=0.48), in 
percentages of cells (t(98.29)=-3.02, p=0.003, d=0.61) or in percentage of cells among CD4+  T Cells 
(t(115)=-2.79, p=0.006, d=0.52). No differences are identified in other cell compartments (cell 
counts: naive, t(109.9)=1.770, p=0.080; CM, t(110)=0.780, p=0.480; LD, U(110)=1545, Z=-0.108, 
p=0.919; percentage of cells: naive, t(115)=0.335, p=0.739; CM, t(115)=0.120, p=0.905; LD, 
U(115)=1545, Z=-0.853, p=0.394; percentage of cells among CD4+ T Cells: naive t(115)=1.713, 
p=0.089; CM, t(115)=0.907, p=0.366; LD, t(115)=0.006, p=0.995).  
Among the CD8+ T cells (Figure 7), the compartment most represented is the LD 
(M=35.29, SD=17.72), followed by EM (M=28.30, SD=13.51) and the two compartments least 
represented are naive (M=13.60, SD=9.92) and CM (M=10.25, SD=6.67). In comparison to the 
good performers, poor cognitive performers present statistically significant lower levels of naive 
CD8+ T cells. The differences are observed either in cell counts (t(93.75)=2.60, p=0.011, d=0.54), in 
percentages of cells (t(111.04)=1.98, p=0.05, d=0.38) and in percentage of cells among CD8+  T Cells 
(t(109.97)=2.06, p=0.042, d=0.39). No differences are identified in other cell compartments (cell 
counts: CM, U(110)=1375, Z=-1.096, p=0.273; EM, t(110)=-0.774, p=0.440; LD, t(110)=-0.332, 
p=0.746; percentage of cells: CM, t(115)=1.231, p=0.221; EM, t(115)=-0.922, p=0.359; LD, t(115)=- 
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Figure 6. Poor Cognitive performers present higher levels of EM CD4+ T cells. Poor cognitive performers 
(black) present statistically significant more EM CD4+ T cells than good performers (white), and no differences are 
observed in other cell compartments of CD4+ T cells (naive, CM and LD cells) (A). The same differences are observed 
regarding percentages of cells among total cells (B), as well as percentages of the different cell compartments 
among CD4+ T cells (C). Each dot represents one individual and the line the mean of the group (*p<0.05; **p<0.01). 
A 
B 
C 
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Figure 7. Poor Cognitive performers present lower levels of Naive CD8+ T cells. Poor cognitive 
performers (black) present statistical significant less naive CD8+ T cells than good performers (white), and no 
differences are observed in other cell compartments of CD8+ T cells (CM, EM and LD cells) (A). The same differences 
are observed regarding percentages of cells among total cells (B), as well as percentages of the different cell 
compartments among CD8+ T cells (C). Each dot represents one individual and the line the mean of the group 
(*p<0.05).  
 
A 
B 
C 
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0.396, p=0.693; percentage of cells among CD8+ T cells: CM, t(115)=1.047, p=0.297; EM, t(115)=-
0.482, p=0.630; LD, t(115)=-0.193, p=0.847). 
CD4+ T cells are characterized by the presence of several cell subsets (such as Th1, Th2, 
Th9, Th17, follicular helper T cells (Tfh), regulatory type 1 cells (Tr1) and Treg) with different 
differentiation processes and functions (Luckheeram et al. 2012). Tregs are an extremely 
important population due to its function on the control of autoimmunity and immune responses 
(Sakaguchi et al. 2008; Fulop et al. 2011; Lefebvre & Haynes 2012). Moreover, some reports 
suggest that this cell type increase with age (Orsini et al. 2012; Gregg et al. 2005; Lefebvre & 
Haynes 2012). Since Tregs need to be maintained in the right proportion in respect to other type 
of cells, particularly other CD4+ T cell populations, a Treg increased has been suggested to 
contribute to the impaired immunity observed in aged individuals (Fulop et al. 2011; Lefebvre & 
Haynes 2012). Even though there are no studies addressing the impact of Tregs on cognitive 
performance, interestingly, studies using mice with self-reactive T cells (CNS-specific T cells) 
indicate that these have a better cognitive performance when compared with mice possessing 
mainly T cells directed to ovalbumin (Ziv et al. 2006).  
Comparing the Tregs between the good and poor cognitive performers (Figure 8), no 
differences are observed in counts (t(106)=0.046, p=0.963), neither in percentages of cells (t(106)=-
0.507, p=0.613) nor in percentages of cells among CD4+ T Cells ( t(111.0)=-0.836, p=0.405). 
 
 
Figure 8. Distinct cognitive performers do not present differences in Tregs.  No statistical differences are 
observed between good (white) and poor (black) cognitive performers in Tregs counts (A), Tregs percentages among 
total cells (B) and Tregs percentages among CD4+ T cells (C). Each dot represents one individual and the line the 
mean of the group.  
A B C 
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4.3. CORRELATIONS OF THE ADAPTIVE IMMUNE CELL POPULATIONS WITH 
MEMORY AND GENERAL EXECUTIVE FUNCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Memory and General Executive Function 
present statistical significant correlations with the 
numbers of cells from some adaptive immune 
populations. Lymphocytes, T cells, CD4+ T cells, naive 
CD4+ T cells, CM CD4+ T cells, naive CD8+ T cells and CM 
CD8+ T cells counts correlate positively with zscores of 
general executive function’s dimension (EXEC), whereas 
EM CD4+ T cells correlate negatively. Regarding memory, 
only T cells, naive CD4+ T cells, naive CD8+ T cells and CM 
CD8+ T cells counts correlate positively with zscores of 
memory’s dimension (MEM), while once more EM CD4+ T 
cells correlate negatively. Each dot represents one 
individual and the line the correlation between the two 
variables. Correlations were evaluated using Pearson 
correlation coefficients (r) test for variables with normal 
distribution and Spearman’s rank correlation coefficients 
(ρ) test for variables with non-normal distribution (*p<0.05; 
**p<0.01; ***p<0.001). 
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The classification of individuals as good and poor cognitive performers was based on their 
scores on memory, general executive function and also mood. However, even within the same 
cluster, individuals present quite diverse scores regarding memory, executive function and mood. 
To explore if there is a correlation between each one of these dimensions and cell populations 
from the immune system we investigated if scores on memory, general executive function and 
mood dimensions were independently correlated with the adaptive immune parameters 
previously analyzed. 
The analysis of cell counts shows that lymphocytes (R2=0.052, p=0.016), T cells 
(R2=0.067, p=0.006), CD4+ T cells (R2=0.042, p=0.030), naive CD4+ T cells (R2=0.039, 
p=0.037), CM CD4+ T cells (R2=0.073, p=0.004), naive CD8+ T cells (R2=0.174, p<0.001) and 
CM CD8+ T cells (R2=0.080, p=0.003) present statistical significant positive correlations with 
zscores of EXEC, whereas EM CD4+ T cells (R2=0.038, p=0.040) correlate negatively (Figure 9).  
T cells (R2=0.043, p=0.028), naive CD4+ T cells (R2=0.06, p=0.009), naive CD8+ T cells 
(R2=0.095, p=0.001) and CM CD8+ T cells counts (R2=0.040, p=0.035) present statistical 
significant positive correlations with zscores of MEM, while EM CD4+ T cells (R2=0.050, p=0.017) 
correlate negatively with zscores of MEM (Figure 9). The coefficient of determination (R2) is a 
measure of the effect size and informs us about the percentage of cognitive scores explained by 
the immune system variables. In the present study, cell counts, of the previously described 
populations that present statistical significant correlations, explain between 4.0 to 9.5% of MEM 
zscore, having a small effect size. For EXEC zscore, cell counts explain between 3.9 to 17.4%, 
being naive CD8+ T cells counts the only one with a medium effect size (17.4%), all the other 
present a small effect size.  
The analysis of cell percentages demonstrated that naive CD8+ T cells (R2=0.091, p=0.001) 
and CM CD8+ T cells (R2=0.078, p=0.002) present a statistical significant positive correlations 
with EXEC zscores, whereas EM CD4+ T cells (R2=0.078, p=0.002) correlate negatively (Figure 
10). The analysis of the MEM dimension shows that statistical significant positive correlations are 
present for the percentage of naive CD8+ T cells (R2=0.056, p=0.010), while once more EM CD4+ 
T cells (R2=0.071, p=0.004) correlate negatively with this dimension (Figure 10). In both memory 
and executive function dimensions, only 5.6 to 9.1% of the scores are explained by the 
percentage of cells analyzed with statistical significant correlations. 
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All the statistical significant correlations found in our study are considered to have low 
(correlation coefficients between 0.1 and 0.29) or moderate associations (correlation coefficient 
between 0.3 and 0.49) (Kotrlik & Williams 2003). 
Since mood was proved to be a key determinant of cognitive performance in the Switchbox 
cohort (Santos et al. 2012) and has also been described to be influenced by the immune system 
profile (Dhabhar et al. 2009; Dowlati et al. 2010; Huang & Lee 2007), correlations between the 
cells of the adaptive immune system analyzed and the zscore for GDS (Annexes Table 4) were 
also performed. Cell counts of CM CD4+ T cells (r=-0.214, p=0.024), naive CD8+ T cells (r=-
0.186, p=0.050), CM CD8+ T cells (ρ=-0.329, p<0.001) and EM CD8+ T cells (r=-0.193, 
p=0.042) present statistical significant negative correlations with the zscores of GDS; meaning, 
higher cell counts correlate with higher (or less “depressed”) mood state (the higher the GDS 
values the higher the depressed mood level). The analysis of cell percentages demonstrated that 
only LD CD4+ T cells (ρ=0.247, p=0.007) present a statistical significant positive correlation.  
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Figure 10. Several percentages of cells 
populations from the adaptive immune system 
present statistical significant correlations with 
either Memory or General Executive Functions. 
Percentage of naive CD8+ T cells and CM CD8+ T cells 
among total cells correlate positively with zscores of 
EXEC, whereas EM CD4+ T cells correlate negatively. 
Regarding memory, only percentages of naive CD8+ T 
cells among total cells correlate positively with zscore 
of MEM, while once more EM CD4+ T cells correlate 
negatively. Each dot represents one individual and the 
line the correlation between the two variables. 
Correlations were evaluated using Pearson correlation 
coefficients (r) test for variables with normal distribution 
and Spearman’s rank correlation coefficients (ρ) test 
for variables with non-normal distribution (*p<0.05; 
**p<0.01; ***p<0.001). 
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4.4. REGRESSION MODELS TO ADDRESS IF ADAPTIVE IMMUNE 
COMPARTMENTS CAN PREDICT COGNITIVE FUNCTIONS  
The immune system and cognitive abilities are highly influenced by age (and also gender). 
In fact, many of the variables analyzed in the study are influenced by age and gender (data not 
shown). To examine whether one or more cell population of the adaptive immune system 
account, even considering gender and age, for the prediction of memory and general executive 
function, two multiple linear regression models were performed. To that purpose, we selected the 
cell populations that presented statistical significant correlations with the cognitive dimensions, 
which were not controlled for age and gender, and included them in the respective model.  
In the prediction models using cell counts of T cell compartments (Table 2), naive CD4+ T 
cells, CM CD4+ T cells (not for MEM model), EM CD4+ T cells, naive CD8+ T cells, gender and age 
were included as independent variables (lymphocytes and CD4+ T Cell counts were collinear; T 
cells and CM CD8+ T cell counts do not present normal distribution and were excluded from the 
model).  
 
Table 2. Multiple linear regression models for cell counts 
 
Statistical significant multiple linear regression models were obtained either for memory or 
to general executive function (MEM, F(5,106)=5.476, p< 0.001; EXEC, F(6,104)=10.123; p<0.001; Table 
2). Thus in both cases, immune cell populations, and taking into account gender and age, were 
shown to predict the value of the zscore of each dimension. In MEM model adjusted R2 were 
approximately 0.17, indicating that about 17% of zscore of memory could be predicted by the 
immune cell populations introduced in the model, gender and age. In EXEC regression model 
adjusted R2 were approximately 0.33, indicating that about 33% of zscore of executive function 
B S.E. t β B S.E. t β
L U L U
Gendera 0.335 0.214 1.564 -0.090 0.760 0.138 0.636 0.209 3.048** 0.222 1.049 0.243
Age 0.028 0.014  1.991* -0.056 0.000 -0.194 -0.047 0.014 -3.476** -0.074 -0.020 -0.306
Naive CD4+ T cells 1.105 0.673 1.641 -0.230 2.440 0.162 0.211 0.662 0.318 -1102 1.523 0.029
CM CD4+ T cells ---- ---- ---- ---- ---- ---- 1.073 0.603 1.780 -0.122 2.268 0.151
EM CD4+ T cells -1.984 0.855 -2.320* -3.679 -0.289 -0.203 -1.749 0.823 -2.124* -3382 -0.116 -0.167
Naive CD8+ T cells 5.010 4.008 1.250 -2.937 1.296 0.134 8.104 3.989 2.031* 0.192 1.602 0.202
*p<0.05; **p<0.01; ***p<0.001
aReference category is male
95% C.I.
MEM EXEC
95% C.I.
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component could be predicted by all the variables introduced in the model (immune cell 
populations, gender and age). Age and EM CD4+ T cells counts proved to be statistical significant 
predictors of memory zscore. Furthermore, since a higher β value is associated with a higher 
impact on the model, EM CD4+ T cells (β=-0.203) has a higher impact on the MEM regression 
model than age (β=-0.194). In the EXEC regression model, age, gender, EM CD4+ T cells and 
naive CD8+ T cells counts proved to be statistical significant predictors of zscore of general 
executive function. The independent variable with higher impact in the model are age (β=-0.306) 
followed by gender (β=0.243), naive CD8+ T cells (β=0.202) and EM CD4+ T cells (β=-0.167). 
In the prediction models using percentages of cells of the T cell compartments studied 
(Table 3), EM CD4+ T cells, naive CD8+ T cells, CM CD8+ T cells (not for MEM model), age and 
gender were included as independent variables. 
 
Table 3. Multiple linear regression models for percentage of cells  
 
Statistical significant multiple linear regression models were obtained for memory and 
general executive function (MEM, F(4,112)=5.971 p<0.001; EXEC, F(5,110)=11.377; p<0.001; Table 3). 
In both cases, the percentage of immune cell populations introduced in the model, gender and 
age determine the value of the zscore of each dimension. In the MEM model the adjusted R2 is 
approximately 0.15, indicating that about 15% of the zscore of memory could be predicted by the 
variables introduced in the model (percentage of EM CD4+ T cells, naive CD8+ T cells, age and 
gender). In the EXEC model the adjusted R2 were approximately 0.31, indicating that about 31% 
of zscore of executive function could be predicted by the percentage of EM CD4+ T cells, naive 
CD8+ T cells, CM CD8+ T cells, age and gender. Only the percentage of EM CD4+ T cells is a 
statistical significant predictor of zscore of memory, whereas age, gender and percentage of EM 
CD4+ T cells are statistical significant predictors of zscore of executive function. In this last model, 
B S.E. t β B S.E. t β
L U L U
Gendera 0.348 0.214 1.628 -0.075 0.771 0.144 0.755 0.212 3.568** 0.336 1.175 0.285
Age -0.027 0.014 -1.900 -0.055 0.001 -0.185 -0.040 0.014 -2.883** -0.068 -0.013 -0.254
EM CD4+ T cells -0.144 0.055 -2.605** -0.253 -0.034 -0.226 -0.147 0.054 -2.707** -0.254 -0.039 -0.212
Naive CD8+ T cells 0.376 0.221 1.698 -0.063 0.814 0.167 0.426 0.227 1.875 -0.024 0.877 0.173
CM CD8+ T cells ---- ---- ---- ---- ---- ---- 0.416 0.238 1.752 -0.055 0.887 0.145
*p<0.05; **p<0.01; ***p<0.001
aReference category is male
MEM EXEC
95% C.I. 95% C.I.
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the variable with a higher impact is gender (β=0.285), followed by age (β=-0.254) and EM CD4+ T 
cells (β=-0.212). In addition to age and/or gender, EM CD4+ T cells proved to be a 
good/significant predictor for both cognitive dimensions in the two models generated. 
Once we obtained correlations between some types of adaptive immune cells studied and 
the zscore of GDS we also decided to examine whether those cells, gender and age could be 
predictors of the GDS. We performed a multiple regression model only for cell counts and not for 
cell percentages. This decision was based on our observation that the only correlation found for 
percentage of cells was in LD CD4+ T cells and since it did not present a normal distribution it 
was not included in a regression model. The independent variables included in the model were 
CM CD4+ T cells, naive CD8+ T cells, CM CD8+ T cells, EM CD8+ T cells counts, gender and age. 
Although a statistical significant model was obtained (F(6,105)=3.524; p=0.003, adjusted R
2=0.120) 
none of the immunological parameters are considered as a statistical significant predictors, and 
significance was only due to gender (Table 4). 
Table 4. Multiple linear regression models for cell counts 
 
 
 
 
 
 
B S.E. t β
L U
Gendera -0.590 0.185 -3.184** -0.957 -0.222 -0.293
Age -0.005 0.012 -0.435 -0.029 0.019 -0.044
EM CD4+ T cells -0.800 0.659 -1.213 -2.107 0.508 -0.146
Naive CD8+ T cells -5.180 3.348 -1.547 -11.819 1.458 -0.168
CM CD8+ T cells 1.236 3.683 0.336 -6.067 8.539 0.045
EM CD8+ T cells -1.493 1.049 -1.424 -3.573 0.586 -0.138
*p<0.05; **p<0.01; ***p<0.001
aReference category is male
GDS
95% C.I.
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In the last years several studies have strongly indicated that cognitive functions are 
dependent on the immune system homeostasis. The absence of T cells or a pro-inflammatory  
cytokine profile has been associated with impaired cognitive performances (Kipnis et al. 2012; 
Dimopoulos et al. 2006; Trollor et al. 2010). It is also known that aging is mostly associated with 
the decline of immune system and cognitive functions. Most human studies investigating the link 
between these two systems commonly compare a younger with an older population, or only look 
for a very restricted set of molecules or one type of immune cell. With this project we investigated 
if the distinct cognitive performances of older individuals are related with a specific 
immunosenescence profile. Until now, no study has been published with a similar approach.    
We found that poor cognitive performances are associated with higher numbers and 
percentages of EM CD4+ T cells. Since these T cells are the major cytokine producers among T 
cells, we hypothesize that an increase in this population could be associated with a more pro-
inflammatory profile, which, in fact, has been associated with cognitive impairments in older 
individuals in previous studies (Dimopoulos et al. 2006; Trollor et al. 2010). This finding 
prompted us to hypothesize that an immune system that aged faster (presents more EM CD4+ T 
cells), can be associated with poorer cognitive performance.  
Exclude or not individuals from the study? 
The participants enrolled in this study are cognitively “healthy” individuals (no diagnosed 
cognitive impairment, dementia and/or neuropsychiatric disorder), who are clinically considered 
as “normal/healthy” agers, particularly considering absence of neuropathology, and/or central 
nervous system disease and/or overt thyroid pathology. However, for the purpose of this work, 
our first approach was to check if their main immune cell populations were within the normal 
range. In fact, most of the participants presented counts of leukocytes and also of its 
subpopulations (neutrophils, lymphocytes, monocytes, basophils and eosinophils) between 
normal values considered for an adult population. Likewise, the compartments of T cells (both 
CD4+ and CD8+ T cells) were in accordance with another study that evaluate the dynamics of T 
cell compartments during aging (Saule et al. 2006). The proportion of the different cell 
compartments in our population was equivalent to the corresponding age match. Although most 
of the participants in the study present normal numbers of leukocyte and their subpopulations 
the presence of outliers in the studied individuals should be taken into consideration. To assess if 
some individuals should be removed from the analysis we checked for how many variables each 
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individual presented values considered outliers (with a confidence level of 99%). For the 47 
variables included in the data base (leukogram values, percentages and counts of lymphocytes, T 
cells and T cell compartments, both CD4+ and CD8+ T cells, and C-reactive protein), only three 
individuals demonstrated to have values considered outliers in more than 15% of the variables 
(two 17% and one 20%). Moreover, when it was assessed in which variables they presented 
values considered outliers it was verified that, for each individual, the majority of the variables 
were in the same cell compartment. Based on this, it was decided that, at this point of the study, 
these findings were not strong enough to exclude any participant from the study. Only individuals 
who presented problems in the sample processing were excluded. In the future, we should cross 
our flow cytometry data analysis results with biochemical data and clinical evaluation in order to 
decide if any participant should be excluded from the study based on multiple parameters. 
Furthermore, besides the mentioned considerations, we would like also to measure 
cytomegalovirus (CMV) antibodies in all the participants, to avoid bias in the results. CMV is a 
chronic infection highly prevalent in older individuals (Staras et al. 2006) that has been 
associated with immunosenescence, mainly with the accumulation of LD CD8+ T cells (Pawelec & 
Derhovanessian 2011). Moreover, a recent study demonstrated that higher cytomegalovirus 
antibody levels are associated with lower general cognitive ability (Gow et al. 2013).  
T cell populations and cognitive performance  
As mention before, our cohort is composed by individuals with normal levels of the main 
immune cell populations. Furthermore when we compared leukocytes and lymphocyte 
subpopulations (total T cells and CD4+ and CD8+ T cells) of the good and poor cognitive 
performers no differences were observed. However, when we evaluated the T cells 
compartments, which undergo dynamic alterations with aging (Saule et al. 2006), the poor 
cognitive performance group presented higher percentages and counts of EM CD4+ T cells and 
lower of naive CD8+ T cells when compared with the good cognitive performers. These results 
prompted us to hypothesize that the immune system of poor cognitive performers aged faster 
than that of the good ones.  
The accumulation of cells within the effector compartment could be associated with the 
low-grade inflammation observed with aging since these cells are the major cytokine producers 
(Okada et al. 2008). Older individuals usually present this low-grade inflammation, but probably 
the poor cognitive performers have a more pronounced pro-inflammatory profile. However, to be 
 49 
 
sure of this link between higher levels of CD4+T effector cells and a pro-inflammatory cytokine 
profile, it will be necessary to quantify the cytokines in plasma, or by flow cytometry to identify 
and quantify the main cytokines produced specifically by these cells (such as, INF-γ, IL-4, IL-5, IL-
10, IL-12, IL-13, IL-17, IL-22, TGF-β (Okada et al. 2008; Jiang & Dong 2013)). Thus, in the 
future, cytokines should be quantified in plasma, collected on the same day as the blood samples 
processed for flow cytometry, to investigate if higher numbers of CD4+ T effector cells (as present 
in poor cognitive performers) are also associated with a specific pro-inflammatory profile. In 
addition, the lower levels of naive CD8+ T cells are in agreement with the possibility of poor 
cognitive performance to be associated with a faster aging of the immune system. It was shown 
that naive CD8+ T cells decline during aging two times faster than naive CD4+ T cells (Saule et al. 
2006) and, because of that, it is easier to identify slight differences in progression of the 
immunosenescence.  
Although still controversial, some studies suggest that Tregs increase during aging. Tregs 
are indispensable to the maintenance of self-tolerance and immune homeostasis (Sakaguchi et 
al. 2008) and since Tregs need to be maintained in the right proportion in respect to other type 
of cells, this Treg increased has been suggested to contribute to the immunosenescence. 
In this study we addressed Tregs and did not find differences between distinct cognitive 
performers. However, it would be interesting to not look only for the overall pool of Tregs, but to 
phenotypes related with its activation state. Actually, we intend to dissect the distinct Tregs 
phenotypes that are described by Sakaguchi and collaborators (Miyara et al. 2009). They 
identified three phenotypically and functional distinct subpopulations of Tregs (two of them with a 
suppressive phenotype): 1) CD45RA+Foxp3low resting Treg cells (rTregs); 2) CD45RA-Foxp3hi 
activated Treg cells (aTregs); and 3) the cytokine-secreting CD45RA-Foxp3low nonsuppressive T 
cells, also defined as memory/effector-like non-Tregs. They also demonstrated that these 
subpopulations present different dynamics during aging. As naive T cells, rTregs decrease during 
aging, while aTregs as well as cytokine-secreting Tregs increase. If Tregs follow the same profile 
of overall CD4+ T cells, we hypothesize that cytokine-secreting Tregs will be increased in poor 
performers contributing to their pro-inflammatory profile.  
Besides the activation state of Treg cells we also aim to discriminate the activation state of 
the different subsets of T cell compartments by the expression of HLA-DR (Sansoni et al. 2008; 
Xiao et al. 2011). Since the pro-inflammatory profile has been previously associated with poor 
cognitive performance in old(er) age, there is the possibility that these older individuals present a 
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higher activation state and consequently produce more cytokines. Moreover, all the alterations 
that we observed in the adaptive immune system between good and poor cognitive performers 
can be also a result of alterations in the innate immune system. Due to this, it would be 
interesting to analyze the main populations of the innate immune system, as well as B cell, to 
clarify the overall immune profile and its correlation with cognitive performance.  
Can mood be a confounding factor?  
In a previous study of the initial cohort, mood was shown to be a key determinant of 
cognitive performance in older individuals, even accounting for age, gender and school education 
(Santos et al. 2012). Specifically, four performance clusters were obtained: two stronger cognitive 
performers’ group that comprised clusters C1 and C2, and two poorer performance group 
comprised of clusters C3 and C4 (where, C1 presented the better cognitive performance and C4 
the worst). It was further demonstrated that that mood was the factor that discriminated among 
the subgroups: C1 vs C2 and C3 vs C4. 
Since in our sample the good cognitive performance group is a pool of individuals from the 
C1 and C2 groups and, likewise, the poor cognitive performance group is composed by C3 and 
C4, we questioned if mood could be affecting the differences observed in the T cells 
compartments between the two distinct cognitive groups. This is relevant as there is an 
increasing body of evidence indicating that pro-inflammatory cytokines are involved in the 
pathophysiology of depression, linking the immune system with neuropsychiatry disorders 
(Dowlati et al. 2010; Huang & Lee 2007; Dhabhar et al. 2009). However, in our sample, 
(depressive) mood does not seem to be a confounding factor in the interplay between immune 
system and cognition. Few correlations were found between adaptive immune cells analyzed and 
mood dimension. Furthermore, the regression model used to predict mood based on adaptive 
immune components (CM CD4+ T cells, naive CD8+ T cells, CM CD8+ T cells and EM CD8+ T cells 
counts), gender and age was extremely poor and none of the immune system cells introduced in 
the model predicted significantly mood. Although apparently mood is not affecting our sample, 
future analysis should take this factor into account and possible include it as covariate.  
T cells and cognitive dimensions: correlations and regression models 
Cognitive performance of the studied individuals was assessed based on memory and 
general cognition and executive function. To understand if the immune cells analyzed could 
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correlate better with these encompassing cognitive dimensions, multiple linear correlations were 
performed between the percentages and cell counts of adaptive immune cell populations and the 
zscores calculated previously for memory and executive function. However, immune system as 
well as cognitive function is highly affected by age and gender, therefore, most of the correlations 
found can be masked by these two factors. In fact, the poor and good cognitive performers 
present statistical significant differences in age (t(117)=-2.268, p=0.025). Individuals of the poor 
group are, on average, older (M=67.71, SD=8.214) than individuals of the good group (M=64.27, 
SD=8.297). To circumvent this problem we selected the significant correlations for memory and 
executive functions and included these variables as predictors in a multiple linear regression 
model that also include as independent variables gender and age. 
We demonstrated that T cell compartments have better predictive power for general 
executive function over memory, since more than 30% of executive function is explained by 
counts (naive CD4+ T cells, CM CD4+ T cells, EM CD4+ T cells and naive CD8+ T cells) or 
percentages of T cell compartments (EM CD4+ T cells, naive CD8+ T cells and CM CD8+ T cells), 
considering also gender and age. On the contrary, in models generated for memory prediction 
only about 15% is explained by T cell compartments (counts: naive CD4+ T cells, EM CD4+ T cells 
and naive CD8+ T cells; percentage: EM CD4+ T cells and naive CD8+ T cells), gender and age. 
Besides gender and/or age, EM CD4+ T cells appear as significant predictor in all prediction 
models and in all of them with a negative effect. This means that higher percentages or counts of 
EM CD4+T cells predict negatively cognitive function. Furthermore, in cell counts regression 
model EM CD4+T cells counts demonstrated to be the only significant predictor of memory and in 
the other regression model, percentages of EM CD4+T cells has proven to contribute more than 
age to memory prediction. All these results lead us to consider that EM CD4+T cells are highly 
associated with cognitive performance prediction. 
These results corroborate the idea that the immune system of poor cognitive performers 
age faster than the good ones, and possibly, the accumulation of EM CD4+T cells contribute to a 
more pro-inflammatory profile.  
Data not published yet by our group demonstrated that a latent cognitive score (that is, a 
“basal cognitive capacity”), calculated using a structural equation modeling based on three 
identified cognitive dimensions (zGENEXEC, zMEM, and a higher-level executive processing 
capacity zDSST) and four predictors (gender, age, school years and GDS), underlies the overall 
performance measured directly via the neurocognitive tests. In fact, in the model, the included 
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variables explained 62% of the variability of the latent cognition score (Nadine Santos, 
unpublished data), indicating that other unknown factors are also of relevance. From the current 
findings, the inclusion of immune system parameters as predictors (mainly percentage or counts 
of EM CD4+ T cells) in the model probably could increase the explanation of the variability of 
cognition.  
Our results demonstrated that the cell population more consistently associated with the 
cognitive performance is EM CD4+T cells. Interestingly in animal studies, CD4+ T cells play a 
central role in cognitive functions when compared with other lymphocyte populations. It was 
shown that systemic depletion of CD4+ T cells significantly reduced hippocampal neurogenesis 
and impaired reversal learning in MWM,  such effects were not observed for CD8+ T cells neither 
B cells (Wolf et al. 2009). Moreover, after a MWM-training it was observed a substantial increase 
in CD4+ but not CD8+ T cells numbers in the meninges of mice (Derecki et al. 2010). 
Additional statistical approaches: cognitive measures  
All the cognitive characterization was conducted based on the initial cohort (n=1051 
participants) (Santos et al., 2012; and, unpublished data). Principal component analysis was 
used to group neurocognitive/psychological test parameters into cognitive/mood dimensions, 
from where participants zscores in each identified dimensions were calculated. Subsequently, 
clustering analysis was conducted to group individuals into distinct performance groups. Here, 
participants were selected from the initial cohort (particularly, from the more “extreme ends” of 
C1 and C4 in terms of cognitive performance, balancing for age and mood via inclusion of 
participants from the middle C2 and C3 groups). This kind of analysis could be performed only 
for the participants enrolled on this work and, possibly, the calculated zscore for each dimension 
would be slightly different and could possibly affect group distribution and consequently the 
correlations and regression models that were obtained. However, since the participants are 
representative of the initial cohort we believe that the new analysis would be relatively similar to 
the initial one and the results would not diverge from the ones here obtained. Perhaps more 
relevant, as mentioned, the cognitive dimensions are based on several 
neurocognitive/psychological tests, where even within the same test different subsections can 
test for specific cognitive abilities, and in the future we intend to explore the correlation between 
each variable individually and the immune system.  
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Concluding remarks  
This study contributed to increase knowledge of the interplay between the immune system 
and cognitive function in older individuals, since it is the first study identifying a phenotype of T 
cells associated with poor cognitive performance. The poor cognitive performers are 
characterized by possessing higher percentages and counts of EM CD4+ T cells. If confirmed in 
further work the findings altogether might warrant future therapies to control cognitive aging by 
modulating the immune system, for instance reducing the peripheral levels of EM CD4+ T cells. It 
would be also interesting to understand if there is an early life immune system phenotype 
(around middle-age), that would predict impaired cognitive function later on. In that situation it 
would be feasible an intervention through the modulation of the immune system with the ability 
to arrest or delay age-related cognitive decline. To address that hypothesis a follow up study 
should be performed with the same objective of this but with the additional variable that is 
“time”.  
To combine aging with quality of life, the identification of factors that contribute to age-
related cognitive decline is of utmost importance. With this study we add one more piece in the 
puzzle, however more studies should be accomplished to better clarify the role of the immune 
system in the modulation of cognitive function.  
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Figure 1. Gating strategy for selection of T cells compartments. In flow cytometry dot plots of whole blood samples we start the 
analysis by selecting singlets (A). To exclude low FSC and SSC debris only cells positive for CD45RA and/or for CD45RO were selected (B). 
Lymphocytes were defined by low SSC and FSC (C) and within this population we delimit the cutoff for CCR7 positive expression (D) and select 
T cells by positive expression of CD3 (E). We subdivide T cells in CD4+ and CD8+ T cells (F) and in both populations we defined CD45RA+ 
CD45RO- and CD45RA-CD45RO+ cells (G). In CD45RA+ CD45RO- , cells positive for CCR7 (gate defined in D) are considered Naïve cells and 
negative cells for CCR7 are considered LD (H). In CD45RA- CD45RO+, cells positive for CCR7 (gate defined in D) are considered CM cells and 
negative cells for CCR7 are considered EM (I). 
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Figure 2. Gating strategy for selection of Tregs. In 
flow cytometry dot plots of PBMCs we start the analysis by 
selecting singlets (A). Lymphocytes were defined by low SSC 
and FSC (B) and within this population we selected CD4+ T 
cells (C). Since Tregs are defined as 
CD3+CD4+CD25+CD127lowFoxp3+ we first select CD127low CD4+ 
T cells (D) and afterwards the CD25+Foxp3+ (E). 
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Table 1. Descriptive statistics of cognitive evaluation.  
 
 
Table 2. Descriptive statistics of cell counts of adaptive immune system. 
 
 
Variables N Min Max Mean SD Skew. Kurt. N Min Max Mean SD Skew. Kurt. N Min Max Mean SD Skew. Kurt.
zMEM 119 -1.70 3.31 .2967 1.20947 .186 -.941 64 -1.10 3.31 1.2448 .73203 .101 2.810 55 -1.70 .64 -.8065 .51609 .939 1.204
zEXEC 118 -2.34 2.70 .0307 1.31811 .308 -.965 64 -.87 2.70 1.0066 .92277 .069 -.860 54 -2.34 .33 -1.1259 .55707 .221 .522
zGDS 119 -1.74 2.54 -.0230 1.02946 .518 -.575 64 -1.74 2.06 -.3426 .93069 .686 -.485 55 -1.58 2.54 .3490 1.02139 .371 -.677
N=population size; Min=Minimum; Max=Maximum; SD= Standard Deviation; Skew.=Skewness; Kurt.=Kurtosis
Total Good Poor
Variables N Min Max Mean SD Skew. Kurt. N Min Max Mean SD Skew. Kurt. N Min Max Mean SD Skew. Kurt.
    Leukocytes 115 3.00 15.20 6.39 1.81 1.51 4.88 60 3.00 12.10 6.36 1.65 0.75 1.32 54 3.50 15.20 6.43 2.01 1.94 6.40
    Neutrophils 115 1.50 10.29 3.74 1.25 1.76 6.52 60 1.50 7.44 3.67 1.06 1.19 3.21 54 1.61 10.29 3.84 1.45 1.87 6.53
    Eosinophils 115 0.00 0.91 0.17 0.14 2.42 8.09 60 0.03 0.69 0.17 0.13 1.99 4.51 54 0.00 0.91 0.18 0.15 2.74 10.55
    Basophils 115 0.00 0.15 0.03 0.02 2.51 11.76 60 0.00 0.15 0.03 0.02 2.98 12.80 54 0.00 0.06 0.03 0.02 0.53 -0.74
    Lymphocytes 115 0.98 4.31 1.96 0.67 1.39 1.96 60 1.01 3.94 2.00 0.68 1.24 1.25 54 0.98 4.31 1.89 0.64 1.72 3.87
    Monocytes 115 0.22 1.06 0.49 0.17 0.92 0.57 60 0.22 0.91 0.48 0.16 0.53 -0.68 54 0.26 1.06 0.50 0.18 1.20 1.30
Lymphocytes 112 1.06 4.14 2.18 0.67 1.18 1.23 59 1.19 4.14 2.23 0.72 1.19 0.99 53 1.06 3.95 2.12 0.62 1.10 1.45
   T cells 112 0.36 8.86 1.66 1.07 3.89 20.67 59 0.36 8.86 1.78 1.30 3.55 16.02 53 0.67 5.31 1.53 0.72 3.03 13.77
      CD4+T cells 112 0.27 2.36 0.94 0.35 1.05 1.93 59 0.27 2.36 0.96 0.39 1.21 2.39 53 0.40 1.61 0.92 0.31 0.55 -0.34
         Naive 112 0.00 0.76 0.29 0.18 0.80 0.01 59 0.01 0.72 0.32 0.18 0.38 -0.90 53 0.00 0.76 0.26 0.17 1.39 2.23
         Central Memory 112 0.02 1.13 0.36 0.18 1.20 2.49 59 0.02 1.13 0.37 0.19 1.35 3.35 53 0.02 0.89 0.35 0.18 0.99 1.32
         Effector Memory 112 0.00 0.69 0.18 0.12 1.13 1.59 59 0.00 0.48 0.15 0.11 1.18 0.96 53 0.02 0.69 0.21 0.13 1.05 1.85
         Late Differentiated 112 0.00 0.21 0.02 0.03 3.35 13.45 59 0.00 0.21 0.02 0.04 3.43 13.50 53 0.00 0.15 0.02 0.03 2.80 9.14
         Tregs 108 0.02 0.13 0.05 0.02 1.54 0.23 59 0.02 0.13 0.05 0.03 1.82 3.33 49 0.02 0.09 0.05 0.02 0.54 -0.72
      CD8+T cells 112 0.06 1.36 0.42 0.26 1.61 3.37 59 0.06 1.36 0.42 0.26 1.69 3.65 53 0.07 1.34 0.43 0.25 1.57 3.50
         Naive 112 0.00 0.16 0.05 0.03 1.27 1.41 59 0.00 0.16 0.06 0.04 0.98 0.19 53 0.01 0.09 0.04 0.02 0.72 -0.53
         Central Memory 112 0.00 0.26 0.04 0.04 2.61 10.85 59 0.00 0.26 0.04 0.04 2.66 10.63 53 0.00 0.15 0.04 0.03 1.86 4.10
         Effector Memory 112 0.01 0.54 0.12 0.09 1.58 3.24 59 0.01 0.39 0.11 0.09 1.46 2.16 53 0.03 0.54 0.13 0.10 1.63 3.69
         Late Differentiated 112 0.00 0.78 0.17 0.15 1.69 3.27 59 0.00 0.57 0.16 0.14 1.18 0.77 53 0.01 0.78 0.17 0.17 2.02 4.54
N=population size; Min=Minimum; Max=Maximum; SD= Standard Deviation; Skew.=Skewness; Kurt.=Kurtosis
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Table 3. Descriptive statistics of percentage of cells of adaptive immune system among total cells. 
 
 
 
Variables N Min Max Mean SD Skew. Kurt. N Min Max Mean SD Skew. Kurt. N Min Max Mean SD Skew. Kurt.
Lymphocytes 117 17.90 58.10 34.39 7.85 0.38 0.11 63 19.00 53.80 34.33 7.02 0.27 0.78 54 17.90 58.10 34.46 8.78 0.43 -0.36
   T cells 117 4.62 76.40 25.68 12.52 2.42 7.12 63 4.62 76.40 26.46 14.28 2.28 5.44 54 11.60 74.80 24.77 10.16 2.41 10.14
      CD4+T cells 117 3.56 40.20 14.91 5.33 1.03 3.27 63 3.56 24.60 14.51 4.51 0.02 -0.07 54 5.31 40.20 15.36 6.16 1.36 3.54
         Naive 117 0.00 20.06 4.68 3.08 1.59 4.89 63 0.17 9.85 4.77 2.56 0.17 -1.15 54 0.00 20.06 4.58 3.62 2.17 6.23
         Central Memory 117 0.20 18.19 5.75 2.68 0.98 2.99 63 0.20 11.81 5.78 2.51 0.41 -0.22 54 0.24 18.19 5.72 2.89 1.45 5.34
         Effector Memory 117 0.03 9.40 2.84 1.91 1.00 0.64 63 0.03 7.66 2.36 1.60 1.14 1.10 54 0.25 9.40 3.41 2.09 0.75 0.07
         Late Differentiated 117 0.00 2.69 0.32 0.48 2.84 9.05 63 0.00 2.69 0.31 0.51 3.11 10.63 54 0.00 2.10 0.33 0.45 2.45 6.85
         Tregs 108 0.32 2.00 0.75 0.33 1.57 3.05 59 0.32 1.72 0.74 0.30 1.27 1.70 49 0.33 2.00 0.77 0.36 1.74 3.65
      CD8+T cells 117 0.76 17.30 6.49 3.04 1.00 1.88 63 0.76 17.30 6.35 3.01 1.09 2.35 54 1.87 16.70 6.65 3.10 0.94 1.69
         Naive 117 0.04 2.78 0.76 0.54 1.39 1.68 63 0.04 2.78 0.85 0.61 1.11 0.65 54 0.13 2.36 0.66 0.43 1.67 3.61
         Central Memory 117 0.02 2.75 0.62 0.46 1.46 3.28 63 0.03 2.75 0.67 0.51 1.56 3.61 54 0.02 1.80 0.56 0.40 1.02 0.52
         Effector Memory 117 0.13 9.31 1.86 1.40 1.92 6.23 63 0.13 5.19 1.75 1.14 0.86 0.52 54 0.44 9.31 1.99 1.65 2.15 6.33
         Late Differentiated 117 0.06 9.72 2.46 1.88 1.13 1.25 63 0.06 7.18 2.40 1.80 0.97 0.19 54 0.28 9.72 2.54 1.98 1.28 2.16
         Naive 117 0.00 62.00 29.96 13.05 0.20 -0.41 63 1.73 62.00 31.86 12.80 0.05 -0.25 54 0.00 58.90 27.75 13.11 0.41 -0.30
         Central Memory 117 2.06 72.30 38.84 13.51 0.17 0.44 63 2.06 71.00 39.89 12.27 0.00 0.85 54 4.47 72.30 37.61 14.84 0.36 0.27
         Effector Memory 117 0.14 71.90 20.12 13.31 1.33 2.48 63 0.14 58.40 17.03 11.42 1.37 2.23 54 1.77 71.90 23.72 14.51 1.21 2.31
         Late Differentiated 117 0.00 27.60 2.38 3.82 3.48 16.81 63 0.01 27.60 2.39 4.29 3.93 19.43 54 0.00 14.00 2.38 3.21 1.97 3.41
         Tregs 113 2.89 12.50 6.18 1.79 0.92 1.57 63 2.89 12.50 6.06 1.97 0.85 0.72 50 3.66 12.50 6.34 1.53 1.30 4.26
         Naive 117 1.47 48.80 13.60 9.92 1.37 1.82 63 2.58 48.80 15.28 11.27 1.21 1.07 54 1.47 34.00 11.64 7.73 1.18 1.02
         Central Memory 117 0.40 33.50 10.24 6.67 0.86 0.51 63 0.45 25.30 10.84 6.13 0.27 -0.58 54 0.40 33.50 9.55 7.25 1.38 1.66
         Effector Memory 117 4.91 71.60 28.30 13.51 0.52 -0.09 63 4.91 58.60 27.74 13.26 0.20 -0.73 54 8.47 71.60 28.95 13.88 0.84 0.49
         Late Differentiated 117 3.86 81.80 35.29 17.72 0.35 -0.68 63 3.86 81.80 35.00 17.30 0.42 -0.27 54 4.98 74.70 35.63 18.35 0.28 -1.02
N=population size; Min=Minimum; Max=Maximum; SD= Standard Deviation; Skew.=Skewness; Kurt.=Kurtosis
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Table 4. Mood (GDS) present statistical significant correlations with percentages and numbers of cells 
from some adaptive immune populations. 
Correlation 
Coefficient 
sig. N
Leukocytes -.121 .200 114
Neurophils -.114 .226 114
Eosinophils1 -.165 .080 114
Basophils1 .056 .556 114
Lymphocytes -.117 .213 114
Monocytes -.024 .799 114
Lymphocytes -.158 .097 112
   T cells1 -.154 .105 112
      CD4+T cells -.137 .150 112
         Naive CD4+T cells .210 .090 66
         CM CD4+T cells -.214 .024 112
         EM CD4+T cells .051 .593 112
         LD CD4+T cells1 .156 .101 112
        Tregs -.056 .561 111
      CD8+T cells -.153 .107 112
         Naive CD8+T cells -.186 .050 112
         CM CD8+T cells1 -.329 .000 112
         EM CD8+T cells -.193 .042 112
         LD CD8+T cells -.033 .731 112
Lymphocytes .065 .488 117
   T cells1 .027 .774 117
      CD4+T cells .096 .304 117
         Naive CD4+T cells .089 .340 117
         CM CD4+T cells -.065 .488 117
         EM CD4+T cells .150 .105 117
         LD CD4+T cells1 .246 .007 117
        Tregs .099 .300 111
      CD8+T cells -.075 .422 117
         Naive CD8+T cells -.069 .458 117
         CM CD8+T cells -.175 .059 117
         EM CD8+T cells -.139 .136 117
         LD CD8+T cells .034 .714 117
1Spearman correlation coefficient
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